You have 9 free searches left this month | for more free features.

nintedanib

Showing 26 - 50 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Idiopathic Pulmonary Fibrosis Trial in Seongnam-si (DWN12088, Pirfenidone, Nintedanib)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Seongnam-si, Korea, Republic of
    Cha Unitersity Bundang Medical Center
Sep 22, 2021

Progressive Fibrosing Interstitial Lung Disease Trial in Morgantown (Nintedanib, Placebo)

Not yet recruiting
  • Progressive Fibrosing Interstitial Lung Disease
  • Nintedanib
  • Placebo
  • Morgantown, West Virginia
    West Virginia University Hospital
Sep 29, 2021

Lung Cancer, Lung Metastases Trial in United States (Nintedanib, Prednisone, Placebo)

Active, not recruiting
  • Lung Cancer
  • Lung Metastases
  • Nintedanib
  • +2 more
  • Boston, Massachusetts
  • +11 more
Jul 19, 2022

All-Case Surveillance of Ofev in Patients With IPF in Japan

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Multiple Locations, Japan
    (unnamed)
Jan 23, 2023

Based on Medical Records That Looks at Characteristics of

Completed
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • +2 more
  • Plymouth, Pennsylvania
    Plymouth Meeting
Nov 12, 2021

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients

Recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • Aachen, Germany
  • +19 more
Jul 26, 2022

Cancer of Pancreas Trial in Dallas (Nintedanib)

Recruiting
  • Cancer of Pancreas
  • Nintedanib
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jul 29, 2021

Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases

Active, not recruiting
  • Lung Diseases, Interstitial
  • Nintedanib
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023

Uterine Cervical Tumors Trial in Worldwide (Nintedanib, Placebo)

Active, not recruiting
  • Uterine Cervical Neoplasms
  • Nintedanib
  • Placebo
  • Bruxelles, Belgium
  • +31 more
Mar 1, 2022

Lung Diseases, Interstitial Trial in Worldwide (Nintedanib (Ofev®), Placebo)

Completed
  • Lung Diseases, Interstitial
  • Nintedanib
  • Placebo
  • Los Angeles, California
  • +42 more
Jan 11, 2023

Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Trial in

Active, not recruiting
  • Stage IB Non-Small Cell Lung Carcinoma AJCC v7
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 4, 2022

NSCLC Trial in France, Germany (Docetaxel, Nintedanib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Angers, France
  • +3 more
Jan 11, 2021

Sarcoma, Soft Tissue Trial in Worldwide (Nintedanib, Ifosfamide)

Terminated
  • Sarcoma, Soft Tissue
  • Brussels, Belgium
  • +12 more
Sep 10, 2021

Esophagogastric Adenocarcinoma Trial in United States (Nintedanib)

Completed
  • Esophagogastric Adenocarcinoma
  • Nintedanib
  • Basking Ridge, New Jersey
  • +5 more
Dec 30, 2020

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

Recruiting
  • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • +4 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022

Cutaneous Malignant Melanoma Trial in Germany (Nintedanib, Nintedanib-Placebo, Paclitaxel)

Completed
  • Cutaneous Malignant Melanoma
  • Nintedanib
  • +2 more
  • Essen, NRW, Germany
  • +9 more
Oct 13, 2020

Scleroderma, Systemic Trial in Worldwide (Microgynon, Nintedanib)

Completed
  • Scleroderma, Systemic
  • Gent, Belgium
  • +9 more
Nov 5, 2020

Idiopathic Pulmonary Fibrosis Trial in United States (Nintedanib, Pulmonary rehabilitation program)

Terminated
  • Idiopathic Pulmonary Fibrosis
  • Nintedanib
  • Pulmonary rehabilitation program
  • Birmingham, Alabama
  • +18 more
May 14, 2021

Patients With Any Advanced Solid Tumors Trial in Villejuif (Nintedanib, Pembrolizumab)

Recruiting
  • Patients With Any Advanced Solid Tumors
  • Villejuif, Val De Marne, France
    Gustave Roussy
Apr 6, 2020

Lung Diseases, Interstitial Trial in Worldwide (Nintedanib)

Completed
  • Lung Diseases, Interstitial
  • Nintedanib
  • Birmingham, Alabama
  • +120 more
Sep 21, 2022

Lung Diseases, Interstitial Trial in Worldwide (Nintedanib)

Completed
  • Lung Diseases, Interstitial
  • Nintedanib
  • Birmingham, Alabama
  • +158 more
Jan 24, 2023

(NIS) Collecting Experiences For IPF in Taiwan

Completed
  • Pulmonary Fibrosis
  • Changhua, Taiwan
  • +9 more
Mar 19, 2021

Medullary Thyroid Cancer (MTC), Differentiated Thyroid Cancer (DTC) Trial in Worldwide (Nintedanib, Placebo)

Completed
  • Medullary Thyroid Cancer (MTC)
  • Differentiated Thyroid Cancer (DTC)
  • Nintedanib
  • Placebo
  • Brugge, Belgium
  • +26 more
Jul 30, 2020

Lung Non-Squamous Non-Small Cell Carcinoma, Radiation-Induced Pneumonitis, Stage II Lung Non-Small Cell Cancer AJCC v7 Trial in

Terminated
  • Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 23, 2020